The shares that will do better in 2020 according to Merril Lynch

Wall Street: indexes at record levels

The fourth quarter on Wall Street appears to be well underway with a market that shows indexes at record levels. Geopolitical tensions and volatility have contributed and could still make a difference in the next seven weeks, the same ones that were missing at the end of 2019. Many on Wall Street believe that value stocks could outperform growth for next year.

How to choose a stock with indexes at record levels

According to Merrill Lynch, stocks with solid fundamentals, attractive yields and an affordable price would be lower on US stock indices than competitors.

In selecting securities for the 2020 portfolio for the US bank there are many Buy securities, stocks that can outperform the markets in 2020 such as, BB&T Corp. It is a financial services company, ninth bank of the United States for deposits and the sixth by number of branches.

Shares that will do better in 2020 according to Merril Lynch

In reality, however, the reason why, according to Merrill Lynch, its securities would be part of that group of actions that can outperform the markets in 2020, lies in the recent announcement of the merger between BB&T and SunTrust that will create the sixth largest US bank. Name: Trust Bank. Another note that could attract attention is the 3.28% dividend yield. Merrill Lynch's price target for BB&T shares is $ 55 against a shareholder consensus that on Wall Street is $ 56.11.

Safe sector on which to invest

If instead you want to look for a defensive action to buy in a safe sector on which to invest, then it is the case to bet directly on the health sector, the biggest investment trend of the future. Cigna Corp. (CI) is the action mentioned in the Merrill Lynch report. The company provides insurance and related services both in the United States and internationally.

Like BB&T, Cigna Corp could also be one of those actions that can outperform markets in 2020 according to Merril Lynch. The third quarter's solid results impressed with revenues that exceeded experts 'expectations and analysts' forecasts. Merrill Lynch observer projections set a price target of $ 258 instead of an analyst consensus at $ 215.69.